Medication-related osteonecrosis of the jaw: An update on the Memorial Sloan Kettering Cancer Center experience and the role of premedication dental evaluation in prevention Journal Article


Authors: Owosho, A. A.; Liang, S. T. Y.; Sax, A. Z.; Wu, K.; Yom, S. K.; Huryn, J. M.; Estilo, C. L.
Article Title: Medication-related osteonecrosis of the jaw: An update on the Memorial Sloan Kettering Cancer Center experience and the role of premedication dental evaluation in prevention
Abstract: Objective: The aim of this study was to investigate the relationship between type of antiresorptive medication and medication-related osteonecrosis of the jaw (MRONJ) onset and the role of premedication dental evaluation (PMDE) in the prevention of MRONJ. Study Design: Our database of patients with MRONJ was reviewed. The Kruskal-Wallis test was used to analyze the onset dose of the 3 frequent medication types associated with MRONJ. To evaluate the role of PMDE in the prevention of MRONJ, all patients on antiresorptive and/or antiangiogenic medications seen in the Dental Service of Memorial Sloan Kettering Cancer Center during a 10-year period were subclassified into 2 groups. Group I comprised patients seen for PMDE before the commencement of A/A and group II patients seen after prior exposure to antiresorptive and/or antiangiogenic medications. Fischer's exact test was used to compare the incidence of MRONJ in both groups. Results: Patients on denosumab developed MRONJ earlier compared with zoledronate and pamidronate (P =.003). Group I had a significantly reduced incidence of MRONJ (0.9%) compared with group II (10.5%) (P <.0001). Dentoalveolar trauma as a precipitating factor between groups I and II was not statistically significant. Conclusions: Denosumab was associated with an earlier occurrence of MRONJ compared with zoledronate and pamidronate. The role of PMDE may be an effective preventive strategy in reducing the incidence of MRONJ. © 2018 Elsevier Inc.
Journal Title: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Volume: 125
Issue: 5
ISSN: 2212-4403
Publisher: Elsevier B.V.  
Date Published: 2018-05-01
Start Page: 440
End Page: 445
Language: English
DOI: 10.1016/j.oooo.2018.02.003
PROVIDER: scopus
PUBMED: 29580668
PMCID: PMC7518027
DOI/URL:
Notes: Article -- Export Date: 1 June 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joseph M Huryn
    109 Huryn
  2. Cherry Estilo
    95 Estilo
  3. SaeHee Kim Yom
    43 Yom
  4. Adepitan Adedamola Owosho
    29 Owosho
  5. Adi Zipora Sax
    4 Sax
  6. Kant Wu
    2 Wu